ABS’ Mission is to advance human health and product safety by providing integrated technology and services to our customers. We serve toxicology, pain management, drug rehabilitation, criminal justice, forensic, environmental, cannabis, and other mature and emerging markets. ABS offers unbiased, OEM-neutral solutions that enable innovation while delivering world-class technical service. We also support our clients and markets with a state-of-the-art reference laboratory. ABS is a Centre Lane Partners portfolio company.
Location: United States, Texas, Carrollton
Employees: 51-200
Phone: +1 866-895-1388
Founded date: 1995
Investors 1
| Date | Name | Website |
| - | Capitala G... | capitalagr... |
Mentions in press and media 7
| Date | Title | Description |
| 08.05.2023 | ABS to Attend the 72nd Annual American Society for Mass Spectrometry Conference | Joe Coffey - Chief Executive Officer, Alternative Biomedical Solutions Alternative Biomedical Solutions ABS to showcase mSPEC™ and its integrated LC-MS/MS product and service offerings, how they can help labs reduce costs, improve efficienc... |
| 18.04.2023 | Alternative Biomedical Solutions to Showcase Innovations in Cannabis and Psychedelic Lab Testing at CannMed23 | ABS Highlights Commitment to Transparency, Quality, and Safety in Cannabis Industry at Premier Medical Cannabis Conference in Marco Island, Florida Bringing clinical rigor to cannabis analytical labs is crucial to ensuring that consumers ha... |
| 14.11.2022 | Alternative Biomedical Solutions To Exhibit at MJBizCon Cannabis Conference | Alternative Biomedical Solutions Adrian Whipple - Chief Financial Officer, Alternative Biomedical Solutions Joe Coffey - Chief Executive Officer, Alternative Biomedical Solutions One-stop partner for starting cannabis analytical labs, lab d... |
| 22.06.2022 | Alternative Biomedical Solutions (ABS) Welcomes Elizabeth Bell as LCMS Business Development Executive (BDE) | ABS Logo LCMS Technical Expert Adds To Deep Commercial Team With Focus on Cannabis Analytical Segment Elizabeth's extensive background in chromatography and mass spectrometry will play a key role in shaping ABS' presence in these (cannabis ... |
| 07.06.2022 | Alternative Biomedical Solutions (ABS) Selects Carrie White as Controller | ABS Logo ABS adds senior finance professional to support future growth. We are thrilled to have Carrie join ABS. She brings with her an impressive record of teamwork and leadership across multiple, complex business environments.” — Adrian W... |
| 05.05.2022 | Alternative Biomedical Solutions (ABS) Appoints Adrian Whipple as Chief Financial Officer | ABS Logo Adrian Whipple, ABS CFO Senior Financial Executive Added to Continue Growth Trajectory In working with Adrian over the past few months, he has already positioned ABS to be increasingly profitable and efficient as we continue our gr... |
| 13.04.2022 | Alternative Biomedical Solutions (ABS) Names Chris Arrington as Sr. Vice President, Core Segments Commercial Operations | ABS Logo Industry veteran focused on taking share and expanding offerings to core customers. We are bullish on our outlook for the Core Segments for the year ahead and much of it is due to the groundwork that Chris has put in place. It’s be... |